-
1Academic Journal
المؤلفون: Sanna Timonen, Vanessa Rebecca Gasparini, Ella Piekkari, Olli Dufva, Shady Awad, Yevhen Akimov, Jana von Jan, Till Braun, Aleksandr Ianevski, Matti Kankainen, Jay Klievink, Marco Herling, Tero Aittokallio, Satu Mustjoki
المصدر: HemaSphere, Vol 7, p e0412416 (2023)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Krimo Toutah (9214896), Nabanita Nawar (8200374), Sanna Timonen (4336672), Helena Sorger (10942366), Yasir S. Raouf (6430028), Shazreh Bukhari (5693024), Jana von Jan (10942369), Aleksandr Ianevski (7461887), Justyna M. Gawel (6430025), Olasunkanmi O. Olaoye (8200389), Mulu Geletu (1343361), Ayah Abdeldayem (10131951), Johan Israelian (9193629), Tudor B. Radu (9214893), Abootaleb Sedighi (1449262), Muzaffar N. Bhatti (10942372), Muhammad Murtaza Hassan (10131954), Pimyupa Manaswiyoungkul (8200386), Andrew E. Shouksmith (1660915), Heidi A. Neubauer (10942378), Elvin D. de Araujo (8200395), Tero Aittokallio (61010), Oliver H. Krämer (5071706), Richard Moriggl (596825), Satu Mustjoki (210642), Marco Herling (2259418), Patrick T. Gunning (545679)
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Cell Biology, Genetics, Molecular Biology, Pharmacology, Cancer, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, KT -531, nontransformed cell lines, hematological cancers, HDAC 6, T-cell prolymphocytic leukemia, HDAC Inhibitors Exhibiting Therapeutic, SAR, T-PLL patient samples, KT -531 synergizes, T-PLL patient cells
-
3
المؤلفون: Till Braun, Jana von Jan, Marco Herling, Linus Wahnschaffe
المصدر: Current Hematologic Malignancy Reports
مصطلحات موضوعية: p53 reactivation, Oncology, Bendamustine, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Hematopoietic stem cell transplantation, T-PLL, Immunotherapy, Adoptive, T cell lymphoma, Cell therapy, Antineoplastic Agents, Immunological, HDAC, Internal medicine, medicine, Animals, Humans, T-cell lymphoma, Molecular Targeted Therapy, Cladribine, Alemtuzumab, Receptors, Chimeric Antigen, Hematology, JAK/STAT inhibition, business.industry, Hematopoietic Stem Cell Transplantation, T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor), medicine.disease, BCL2 antagonists, Treatment Outcome, Leukemia, Prolymphocytic, T-Cell, T-cell prolymphocytic leukemia, Diffusion of Innovation, business, Forecasting, medicine.drug
-
4
المؤلفون: Patrick T. Gunning, Yasir S. Raouf, Muhammad Murtaza Hassan, Jana von Jan, Aleksandr Ianevski, Muzaffar N. Bhatti, Justyna M. Gawel, Mulu Geletu, Pimyupa Manaswiyoungkul, Nabanita Nawar, Elvin D. de Araujo, Helena Sorger, Olasunkanmi O. Olaoye, Tero Aittokallio, Oliver H. Krämer, Marco Herling, Sanna Timonen, Ayah Abdeldayem, Krimo Toutah, Tudor B. Radu, Richard Moriggl, Shazreh Bukhari, Johan Israelian, Heidi A. Neubauer, Satu Mustjoki, Andrew E. Shouksmith, Abootaleb Sedighi
المساهمون: Computational Systems Medicine, TRIMM - Translational Immunology Research Program, Institute for Molecular Medicine Finland, Helsinki Institute for Information Technology, Tero Aittokallio / Principal Investigator, Bioinformatics, HUS Comprehensive Cancer Center, Department of Clinical Chemistry and Hematology, Clinicum
المصدر: Journal of Medicinal Chemistry
مصطلحات موضوعية: Male, Pyrrolidines, medicine.medical_treatment, TUBULIN, Apoptosis, SUBEROYLANILIDE HYDROXAMIC ACID, Histone Deacetylase 6, Hydroxamic Acids, 01 natural sciences, Targeted therapy, Mice, chemistry.chemical_compound, Drug Discovery, para-Aminobenzoates, Bendamustine Hydrochloride, Prolymphocytic leukemia, RICOLINOSTAT, Sulfonamides, 0303 health sciences, Molecular Structure, Chemistry, Drug Synergism, 3. Good health, Molecular Docking Simulation, Molecular Medicine, medicine.drug, Bendamustine, ACCURATE DOCKING, EXPRESSION, 3122 Cancers, BORTEZOMIB, Antineoplastic Agents, BCL-2 INHIBITOR, Article, Structure-Activity Relationship, 03 medical and health sciences, HISTONE DEACETYLASE INHIBITOR, Cell Line, Tumor, medicine, Animals, Humans, Epigenetics, COMBINATION, 030304 developmental biology, Venetoclax, HDAC6, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, 0104 chemical sciences, Histone Deacetylase Inhibitors, MODEL, 010404 medicinal & biomolecular chemistry, Leukemia, Prolymphocytic, T-Cell, Cancer research, T-cell prolymphocytic leukemia, Histone deacetylase